Yoshida Junko, Yokoo Seiichi, Oshikata-Miyazaki Ayumi, Amano Shiro, Takezawa Toshiaki, Yamagami Satoru
a Department of Ophthalmology , University of Tokyo Graduate School of Medicine , Hongo, Bunkyo-ku, Tokyo , Japan.
b Division of Animal Sciences , National Institute of Agrobiological Sciences , Ohwashi, Tsukuba , Ibaraki , Japan.
Curr Eye Res. 2017 Nov;42(11):1420-1425. doi: 10.1080/02713683.2017.1351568. Epub 2017 Sep 21.
To evaluate the effect of transplanting bioengineered corneal endothelial grafts in a rabbit model of corneal endothelial failure.
Human corneal endothelial cells (HCECs) were seeded on a vitrigel carrier. After Descemet's membrane was removed from the eyes of rabbits, transplantation was done with a vitrigel/HCEC graft or vitrigel alone without cells, or the eyes were left untreated. Slit lamp examinations and measurement of the central corneal thickness (CCT) were performed for 14 days postoperatively.
HCECs cultured on vitrigel were strongly positive for ZO-1 and Na+/K+ ATPase. On day 14, the cornea showed mild edema and the pupil margins were visible through the grafts in the vitrigel/HCEC graft group. HCECs completely covered the grafts on day 14. In contrast, there was severe corneal edema and the pupil margins were undetectable on day 14 after transplantation of the vitrigel carrier alone or no transplantation. Proliferation of host cells was not observed in these groups. On day 14, the mean CCT was significantly thinner in the vitrigel/HCEC graft group than in the other two groups (p = 0.0008).
Transplantation of a vitrigel/HCEC graft was effective for reducing the corneal thickness and restoring corneal transparency, suggesting the usefulness of vitrigel as a carrier for corneal endothelial cells.
评估在兔角膜内皮功能衰竭模型中移植生物工程角膜内皮移植物的效果。
将人角膜内皮细胞(HCECs)接种于玻璃凝胶载体上。从兔眼中去除Descemet膜后,用玻璃凝胶/HCEC移植物或无细胞的单纯玻璃凝胶进行移植,或不进行处理。术后14天进行裂隙灯检查并测量中央角膜厚度(CCT)。
在玻璃凝胶上培养的HCECs对紧密连接蛋白1(ZO-1)和钠钾ATP酶呈强阳性。在第14天,玻璃凝胶/HCEC移植物组角膜出现轻度水肿,通过移植物可看到瞳孔边缘。在第14天,HCECs完全覆盖了移植物。相比之下,单独移植玻璃凝胶载体或未进行移植后第14天,角膜出现严重水肿且无法检测到瞳孔边缘。这些组中未观察到宿主细胞增殖。在第14天,玻璃凝胶/HCEC移植物组的平均CCT显著低于其他两组(p = 0.0008)。
玻璃凝胶/HCEC移植物移植对于减少角膜厚度和恢复角膜透明度有效,提示玻璃凝胶作为角膜内皮细胞载体的有用性。